1
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Intrauterine progestin therapy as a new approach to premalignant endometrial polyps: A prospective observational study
1
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Low-dose LNG-IUS as therapy for endometrial hyperplasia. A prospective cohort pilot study
1
Anne Ørbo,
Marit Arnes,
Anne Beate Vereide,
Bjørn Straume
:
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens
BJOG: An International Journal of Obstetrics and Gynaecology 2016
DOI /
ARKIV
1
Olesya Popova,
Claes Gøran Tropé,
Erik Rokkones,
Janne Kærn,
Torbjørn Paulsen,
Helga Salvesen
m.fl.:
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"
1
Anne Ørbo,
Anne Beate Vereide,
Marit Arnes,
Inger Pettersen,
Bjørn Straume
:
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial
BJOG: An International Journal of Obstetrics and Gynaecology 2014
DOI /
ARKIV
1
Bjørn Torvald Greve Moe,
Anne Beate Vereide,
Anne Ørbo,
Georg Sager
:
High Concentrations of Progesterone and Mifepristone Mutually Reinforce Cell Cycle Retardation and Induction of Apoptosis
Anticancer Research 2009
ARKIV
1
Bjørn Torvald Greve Moe,
Anne Beate Vereide,
Anne Ørbo,
ragnhild JÆger,
Georg Sager
:
Levonorgestrel, Medroxyprogesterone and Progesterone Cause a Concentration-dependent Reduction in Endometrial Cancer (Ishikawa) Cell Density, and High Concentrations of Progesterone and Mifepristone Act in Synergy
Anticancer Research 2009
ARKIV
1
Anne Ørbo,
marit Arnes,
Christine Hancke,
Anne Beate Vereide,
Inger Pettersen,
Kurt Larsen
:
Treatment results of endometrial hyperplasia after prospective D-score classification - A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only
1
Anne Beate Vereide,
Turid Kaino,
Georg Sager,
Marit Arnes,
Anne Ørbo
:
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia
Gynecologic Oncology 2006
ARKIV
1
Anne Beate Vereide,
Turid Kaino,
Georg B Sager,
Anne Ørbo
:
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: A comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone
Gynecologic Oncology 2005
ARKIV
1
Anne Beate Vereide,
Marit Arnes,
Bjørn Straume,
Jan Martin Maltau,
Anne Ørbo
:
Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone
Gynecologic Oncology 2004
ARKIV
Bjørn Thorvald Greve Moe,
Anne Ørbo,
Georg Sager,
Anne Beate Vereide
:
Extranuclear steroid-initiated signaling by progestin and mifepristone: concentration-dependent inhibition of Ishikawa cell proliferation and induction of apoptosis
Virchows Archiv 2011
ARKIV
Anne Ørbo,
Bjørn greve Moe,
Georg Sager,
Anne Beate Vereide
:
Extranuclear steroid-initiated signaling by progestin and mifepristone
Anne Beate Vereide,
Anne Ørbo
:
Progestin effects on endometrial growthIn vivo and in vitro studies
UiT Norges arktiske universitet 2006
ARKIV
Anne Beate Vereide,
Anne Ørbo
:
progestineffekter på endometrievekst
Anne Ørbo,
Anne Beate Vereide
:
Fra forskning til klinisk praksis
Anne Ørbo,
Anne Beate Vereide
:
Status for levonovastudien
Anne Beate Vereide,
Anne Ørbo
:
Hva fikk vi ut av pilotstudien
Anne Ørbo,
Anne Beate Vereide
:
Behandling og oppfølging av endometriehyperplasi
Anne Beate Vereide,
Anne Ørbo
:
Levonovastudien: En oppdatering
Anne Ørbo,
Anne Beate Vereide
:
Behandling og oppfølging av endometriehyperplasi levonovastudien
Anne Ørbo,
Anne Beate Vereide
:
Behandling og oppfølging av endometriehyperplasi